- Home
- VIOT vs KLTOW Comparison
VIOT vs KLTOW Comparison
Compare VIOT & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIOT
- KLTOW
- Stock Information
- Founded
- VIOT 2014
- KLTOW N/A
- Country
- VIOT China
- KLTOW United States
- Employees
- VIOT N/A
- KLTOW 3
- Industry
- VIOT Consumer Electronics/Appliances
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VIOT Consumer Discretionary
- KLTOW Health Care
- Exchange
- VIOT Nasdaq
- KLTOW Nasdaq
- Market Cap
- VIOT N/A
- KLTOW N/A
- IPO Year
- VIOT 2018
- KLTOW 2022
- Fundamental
- Price
- VIOT $1.37
- KLTOW $0.02
- Analyst Decision
- VIOT
- KLTOW
- Analyst Count
- VIOT 0
- KLTOW 0
- Target Price
- VIOT N/A
- KLTOW N/A
- AVG Volume (30 Days)
- VIOT 242.7K
- KLTOW N/A
- Earning Date
- VIOT 03-25-2025
- KLTOW N/A
- Dividend Yield
- VIOT N/A
- KLTOW N/A
- EPS Growth
- VIOT N/A
- KLTOW N/A
- EPS
- VIOT 0.13
- KLTOW N/A
- Revenue
- VIOT $290,307,298.00
- KLTOW N/A
- Revenue This Year
- VIOT $15.62
- KLTOW N/A
- Revenue Next Year
- VIOT $12.98
- KLTOW N/A
- P/E Ratio
- VIOT $4.71
- KLTOW N/A
- Revenue Growth
- VIOT N/A
- KLTOW N/A
- 52 Week Low
- VIOT $0.50
- KLTOW N/A
- 52 Week High
- VIOT $2.38
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- VIOT 40.58
- KLTOW N/A
- Support Level
- VIOT $1.34
- KLTOW N/A
- Resistance Level
- VIOT $1.56
- KLTOW N/A
- Average True Range (ATR)
- VIOT 0.16
- KLTOW 0.00
- MACD
- VIOT -0.02
- KLTOW 0.00
- Stochastic Oscillator
- VIOT 14.00
- KLTOW 0.00
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.